Albany Molecular Res (AMRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 51,047 | 23,899 | 136,884 | 167,337 | 176,642 |
| Receivables | 79,048 | 61,511 | 65,021 | 66,478 | 59,739 |
| Inventories | 49,880 | 56,020 | 44,277 | 35,279 | 31,991 |
| Income taxes - deferred | N/A | 4,311 | 4,311 | 3,017 | 3,586 |
| TOTAL | $188,541 | $158,976 | $260,818 | $280,419 | $279,019 |
| Non-Current Assets | |||||
| PPE Net | 165,475 | 165,926 | 131,619 | 127,365 | 127,775 |
| Intangibles | 94,326 | 97,502 | 32,214 | 3,033 | 3,042 |
| Other Non-Current Assets | 67,526 | 110,632 | 95,499 | 90,674 | 35,432 |
| TOTAL | $327,327 | $374,060 | $259,332 | $221,072 | $166,249 |
| Total Assets | $515,868 | $533,036 | $520,150 | $501,491 | $445,268 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 447 | 407 | 406 | 1,024 | 1,024 |
| Accounts payable and accrued liabilities | 32,160 | 41,081 | 32,685 | 26,855 | 24,179 |
| Accrued Expenses | 4,235 | 546 | 681 | 847 | 6,806 |
| Other current liabilities | 327 | 669 | 669 | 1,351 | 1,351 |
| TOTAL | $48,690 | $54,634 | $50,130 | $39,067 | $48,849 |
| Non-Current Liabilities | |||||
| Long Term Debt | 155,895 | 123,571 | 122,154 | 124,349 | 123,135 |
| Deferred Revenues | 11,171 | 11,931 | 9,038 | 7,319 | 6,588 |
| Other Non-Current Liabilities | 69,461 | 109,152 | 93,509 | 83,468 | 29,970 |
| TOTAL | $225,356 | $233,203 | $216,709 | $209,893 | $155,662 |
| Total Liabilities | $274,046 | $287,837 | $266,839 | $248,960 | $204,511 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,745 | 32,607 | 32,478 | 32,364 | 32,328 |
| Common Shares | 381 | 380 | 379 | 378 | 370 |
| Retained earnings | 79,632 | 81,493 | 90,134 | 91,357 | 82,910 |
| Other shareholders' equity | -14,065 | -11,039 | -10,557 | -10,914 | -11,329 |
| TOTAL | $241,822 | $245,199 | $253,311 | $252,531 | $240,757 |
| Total Liabilities And Equity | $515,868 | $533,036 | $520,150 | $501,491 | $445,268 |